Skip to main content

Table 1 Patient characteristics

From: Role of vascular function in predicting arteriovenous fistula outcomes: an observational pilot study

Variable AVF creation (%), n = 28 No AVF creation (%), n = 24 Entire cohort (n = 52)
Age 72 (62-78) 71 (51-77) 71.5 (59.5 - 77.5)
Gender: Male 21 (75%) 16 (67%) 37 (71%)
Etiology of CKD
Diabetes mellitus 8 (29%) 7 (29%) 15 (29%)
 Hypertension 9 (32%) 5 (21%) 14 (27%)
 Glomerulonephritis 1 (4%) 3 (13%) 4 (8%)
 Obstruction 1 (4%) 2 (8%) 3 (6%)
 Other 9 (32%) 7 (29%) 16 (31%)
 Diabetes mellitus 14 (56%) 14 (58%) 28 (57%)
 Hypertension 27 (100%) 22 (92%) 49 (96%)
 Coronary artery disease, CAD 5 (50%) 5 (45%) 10 (48%)
 Family history of CAD 1 (9%) 2 (18%) 3 (14%)
 Smoker 4 (15%) 3 (13%) 7 (14%)
 Peripheral vascular disease 3 (27%) 3 (27%) 6 (27%)
 Dyslipidemia 8 (62%) 7 (58%) 15 (60%)
eGFR, ml/min/1.7 m2 15 (12-18) 24 (19-31) 17.5 (13 - 25)
Laboratory variables
 Hemoglobin, g/L 121 ± 14 121 ± 16) 121 (15)
 Creatinine, umol/L 343 ± 88 231 ± 57) 291.54 ± 93.54
 Urine microalbumin: creatinine ratio 285 (80-377) 15 (9-111) 95.7 (11.3 - 295)
 Urine Protein: Cr ratio 0.36 (0.10-0.49) 0.03 (0.02-0.14) 0.11 (0.03 - 0.38)
Systolic blood/diastolic pressure left arm 135 (127-153)/78(70-88) 125 (115-148)/75 (68-83) 131.5 (119 - 149)/76 (69 – 85)
Mean arterial pressure 94 (89-106) 93 (84-101) 94 (87.67 - 104)
Beta blocker 8 (29) 3 (12) 11 (21)
Statin 9 (32) 5 (21) 14 (27)